[
  {
    "ts": "2026-01-21T10:04:06+00:00",
    "headline": "Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52",
    "summary": "The board of Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be paying its dividend of $2.52 on the 6th of March...",
    "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-announced-increasing-100406005.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6bdbf0fd-0a67-3ba6-810f-dcb50527ac55",
      "content": {
        "id": "6bdbf0fd-0a67-3ba6-810f-dcb50527ac55",
        "contentType": "STORY",
        "title": "Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52",
        "description": "",
        "summary": "The board of Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be paying its dividend of $2.52 on the 6th of March...",
        "pubDate": "2026-01-21T10:04:06Z",
        "displayTime": "2026-01-21T10:04:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-announced-increasing-100406005.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-announced-increasing-100406005.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T12:11:01+00:00",
    "headline": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks. On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. telehealth firm, alongside Amgen, aims to investigate barriers patients face in accessing obesity treatments, including GLP-1 drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s […]",
    "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "824c792e-c545-3d09-8882-66f25c349abb",
      "content": {
        "id": "824c792e-c545-3d09-8882-66f25c349abb",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best undervalued wide moat stocks. On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S. telehealth firm, alongside Amgen, aims to investigate barriers patients face in accessing obesity treatments, including GLP-1 drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s […]",
        "pubDate": "2026-01-21T12:11:01Z",
        "displayTime": "2026-01-21T12:11:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8",
          "originalWidth": 4069,
          "originalHeight": 2713,
          "caption": "Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sunxx6hqXfBWKrzfL3htQg--~B/aD0yNzEzO3c9NDA2OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8.cf.webp",
              "width": 4069,
              "height": 2713,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2LdiLb4t.zgVLda0bwZNgg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/89c0b31c8a49a4b2c6733fddd0910df8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-expands-obesity-strategy-121101061.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T13:00:00+00:00",
    "headline": "Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer",
    "summary": "Following its recent $16.5 million Series A financing in December, Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, announced the appointment of Ann Hyllengren as Chief Financial Officer to support the company's next phase of growth.",
    "url": "https://finance.yahoo.com/news/ember-lifesciences-appoints-ann-hyllengren-130000142.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "0f1f1b25-9491-3e8b-b54b-d3c8d7156b54",
      "content": {
        "id": "0f1f1b25-9491-3e8b-b54b-d3c8d7156b54",
        "contentType": "STORY",
        "title": "Ember LifeSciences appoints Ann Hyllengren as Chief Financial Officer",
        "description": "",
        "summary": "Following its recent $16.5 million Series A financing in December, Ember LifeSciences, Inc., a leading provider of revolutionary cold chain technology, announced the appointment of Ann Hyllengren as Chief Financial Officer to support the company's next phase of growth.",
        "pubDate": "2026-01-21T13:00:00Z",
        "displayTime": "2026-01-21T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/bcaa926174d265de18a8fcba65f10fe8",
          "originalWidth": 346,
          "originalHeight": 400,
          "caption": "Ann Hyllengren, CFO",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R3HfzYpq6Fk99RlNnU24Wg--~B/aD00MDA7dz0zNDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/bcaa926174d265de18a8fcba65f10fe8.cf.webp",
              "width": 346,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C5vyjkmkRdYZyl0s1hYbTw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/bcaa926174d265de18a8fcba65f10fe8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ember-lifesciences-appoints-ann-hyllengren-130000142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ember-lifesciences-appoints-ann-hyllengren-130000142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T14:02:00+00:00",
    "headline": "Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference",
    "summary": "SAN DIEGO, January 21, 2026--Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.",
    "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b028eac3-64bb-3971-aaca-c715dc8f6d5f",
      "content": {
        "id": "b028eac3-64bb-3971-aaca-c715dc8f6d5f",
        "contentType": "STORY",
        "title": "Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference",
        "description": "",
        "summary": "SAN DIEGO, January 21, 2026--Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.",
        "pubDate": "2026-01-21T14:02:00Z",
        "displayTime": "2026-01-21T14:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed",
          "originalWidth": 1000,
          "originalHeight": 328,
          "caption": "Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities. Learn more and register: https://www.biocomglobalpartnering.org.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gA7YWJhDU8zLmyCnZeuToQ--~B/aD0zMjg7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed.cf.webp",
              "width": 1000,
              "height": 328,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zJiVOJSw7_VJMxhZmA2BmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]